Satsuma Pharmaceuticals
Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to bringing novel treatments to people who suffer from migraine and other debilitating conditions. Satsuma Pharmaceuticals is a spinout company from the Japanese firm Shin Nippon Biomedical Laboratories (SNBL).
Last updated on
About Satsuma Pharmaceuticals
Founded
2016Estimated Revenue
$1M-$10MEmployees
1-10Funding / Mkt. Cap
$154MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
South San FranciscoState
CaliforniaCountry
United StatesSatsuma Pharmaceuticals
Find your buyer within Satsuma Pharmaceuticals
Tech Stack (59)
.png)
